Navigation Links
AMPAC Fine Chemicals Continues to Invest in Quality Systems
Date:2/14/2012

to ensuring patient safety by enhancing quality and authenticity throughout the supply chain.  The mission of the new organization is timely in light of growing attacks and threats to an increasingly complex and global supply chain.  Millions of people around the world are treated every day with the vital medicines that pharmaceutical and biotechnology companies provide.  Management of the pharmaceutical supply chain has become one of the top public health concerns with respect to consumer safety.  The globalization of distribution for both drug components and finished products has introduced many complications that Rx-360 is positioned to help resolve.  To learn more about Rx-360 go to the Rx-360 website at www.Rx-360.org.

ABOUT AMPAC FINE CHEMICALS LLC
AFC is a U.S.-based company with demonstrated capabilities in process development, scale-up, and cGMP-compliant commercial production of active pharmaceutical ingredients (API's) and registered intermediates for pharmaceutical and biotechnology customers.  Its specially engineered facilities and experienced staff allow AFC to safely produce highly energetic compounds at commercial scale.  In addition, AFC's other technology platforms include production of highly potent compounds, continuous processes and industrial-scale chromatographic separation using simulated moving bed chromatography (SMB).  AFC's operations are located in Rancho Cordova, CA and in La Porte, Texas.  Additional information about us can be obtained by visiting our web site at www.ampacfinechemicals.com.

ABOUT AMERICAN PACIFIC CORPORATION
American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets.  We supply active pharmaceutical ingredients and advanced intermediates
'/>"/>

SOURCE American Pacific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AMPAC Fine Chemicals Completes Contract Manufacturing Agreement for Smallpox Countermeasure API
2. AMPAC Fine Chemicals Validates Continuous Extraction Process for API Manufacture
3. AMPAC Fine Chemicals Announces the Inauguration of the New cGMP Continuous Processing Development Facility
4. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
5. Bio architecture lab technology converts seaweed to renewable fuels and chemicals
6. Reportlinker Adds Global Immunochemicals Industry
7. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
8. Agrivida Announces Collaboration With Syngenta Ventures to Deliver Low-Cost Sugars for Cellulosic Biofuels and Biochemicals
9. Chemicals study pinpoints threat to workers lungs
10. AloeSafe™ Hand Sanitizer is Free From Toxic Chemicals
11. 21st Century Biochemicals Marks Its Third Consecutive Year on the Inc. 5000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 /CNW/ - Resverlogix ... it has completed a collaborative research program ... analytics.  Using Fast Collective Evolution Technology (FACET), ... including all measurements obtained from each of ... Phase 2 clinical trials ASSERT, SUSTAIN and ...
(Date:3/4/2015)... Proove Biosciences , a ... excited to announce the launch of their CME-accredited ... Management of Pain”. , The continuing medical education ... next year. The focus of the program is ... pain treatments, integrate appropriate pain management techniques, and ...
(Date:3/4/2015)... , March 4, 2015  BioClinica®, Inc., ... technology provider, today announced that clinical trial ... convened at its annual European User Conference ... to discuss the use of its eClinical ... eClinical technologies include: the Microsoft Office-Smart OnPoint ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... the fastest growing technologies in the life sciences industry. ... is driving growth in nucleic acid detection technologies like ... gene expressions will continue to benefit the qPCR and ... ranging from pharma, biotech, food & beverage to animal ...
Breaking Biology Technology:Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4
... - Treatment completed in Albuferon(R) Phase 3 trials; first Phase 3 data in ... December 2008 -, - Enrollment completed in LymphoStat-B(R) Phase 3 ... data in mid-2009 - ... - HGS updates financial guidance -, ROCKVILLE, Md., Nov. 6 Human Genome Sciences,Inc. (Nasdaq: ...
... SEATTLE, Nov. 6 /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ:,ONTY) (TSX: ... and nine months ending September 30, 2008., Total ... three and nine,month periods ended September 30, 2008, compared ... in 2007. The increase in total revenue,for the nine ...
... Calif., Nov. 6 Accuray,Incorporated (Nasdaq: ARAY ... radiosurgery,announced today that in conjunction with its independent ... financial results for the first,quarter of fiscal 2009, ... allegations by a former employee of possible,improprieties in ...
Cached Biology Technology:Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments 2Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments 3Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments 4Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments 5Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments 6Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments 7Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments 8Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments 9Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments 10Oncothyreon reports third quarter 2008 financial results 2Oncothyreon reports third quarter 2008 financial results 3Oncothyreon reports third quarter 2008 financial results 4Oncothyreon reports third quarter 2008 financial results 5Accuray Postpones Release of First Quarter Fiscal 2009 Results 2
(Date:1/22/2015)... Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the addition ... report to their offering. , The primary ... is who she/he is claiming to be, and for this ... physical characteristics, such as fingerprint, hand or palm print, iris, ...
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading source ... launch of its new website design. "When we ... infancy", says Peter O,Neill , founder and CEO of ... industry needs involvement from the key players on a very ...
(Date:1/22/2015)... 2015 Technology Showcase, Hall E -   EyeLock Inc. ... announced it will showcase its EyeLock ID technology integrated in ... of Energy,s Oak Ridge National Laboratory (ORNL) at ... iris identity authentication technology is being used to validate the ...
Breaking Biology News(10 mins):Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... impact on levels of carbon dioxide in the Earth,s atmosphere ... that includes starfish and sea urchin has been significantly underestimated. ... sink into account," says Mario Lebrato, lead author of the ... National Oceanography Centre, Southampton (NOCS) and affiliated with the University ...
... in Atlantic puffins could be due to worsening conditions within ... scientific journal Marine Biology . The study used geolocation ... Nature Reserve, home to the largest colony of puffins in ... May has declined by 30% in recent years. The ...
... WORCESTER, Mass. A collaboration between the University ... Medicine at Tufts University and the Broad Institute at ... locus on canine chromosome 7 which coincides with an ... findings, published in the January 2010 edition of ...
Cached Biology News:Echinoderms contribute to global carbon sink 2Where do puffins go in the winter? 2Canine compulsive disorder gene identified 2
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Yersinia pestis...
Insect Cell Lysis Buffer 50 ml...
Rabbit polyclonal to Orexin Prepro ( Abpromise for all tested applications). entrezGeneID: 3060 SwissProtID: O43612...
Biology Products: